| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3924 | Oroidin Hydrochloride | Inhibitor of an enzyme responsible for the multidrug resistance phenotype in the yeast Saccharomyces cerevisiae. |
|
| DCC3925 | Orp-101 | Peripheral weak partial mu-opioid receptor agonist and a weak kappa-opioid receptor antagonist, preventing from being absorbed and entering the central nervous system |
|
| DCC3926 | Ortataxel | Second-generation taxane derivative with potential antineoplastic activity, binding to and stabilizing tubulin molecules, inhibiting cell division and cellular proliferation |
|
| DCC3927 | Oseltamivir Hydrochloride | Inhibitor of the influenza neuramidase enzyme, blocking neuraminidases on the surfaces of influenza viruses, interfering with host cell release of complete viral particles |
|
| DCC3928 | Osi-296 | Novel potent, orally efficacious, dual inhibitor of cMET and RON kinases |
|
| DCC3929 | Osi-461 | Novel cGMP phosphodiesterase (cGMP-PDE) inhibitor |
|
| DCC3930 | Osl-95ii | Inhibitor of the glycan-processing enzyme endoplasmic-reticular glucosidase |
|
| DCC3931 | Osteoclast Differentiation Inhibitor T63 | Novel inhibitor of osteoclast differentiation through regulating MAPKs and Akt signaling pathways |
|
| DCC3932 | Osteoprotegerin | Soluble secreted member of the tumor necrosis factor receptor superfamily, inhibiting osteoclastogenesis by interrupting the signaling between stromal cells and osteoclastic progenitor cells, leading to excess accumulation of bone and cartilage |
|
| DCC3933 | Osteosarcoma-in-d14 | Novel Inhibitor of Migration and Invasion of Osteosarcoma Cells Mediated by p53, Regulating EMT-Related Genes |
|
| DCC3934 | Osteosarcoma-in-d15 | Novel Inhibitor of Migration and Invasion of Osteosarcoma Cells Mediated by p53, Regulating EMT-Related Genes |
|
| DCC3935 | Osu-53 | Novel AMPK activator, inhibiting mTOR signaling and autophagy stimulation, activating mutations in RAS or BRAF |
|
| DCC3936 | Ota-5781 | Novel potent inhibitor of the natural function of FDX1, promoting a unique form of copper-dependent cell death |
|
| DCC3937 | Ouabain | Natural inhibitor of the Na+/K+-ATPase sodium-potassium ion pump |
|
| DCC3938 | oup-186 | High affinity and human/rat species-selective histamine H3 receptor antagonist |
|
| DCC3939 | Ova257-264 Peptide | Ovalbumin fragment peptide as a class I (Kb)-restricted peptide epitope, triggering T cell activation in immunology studies |
|
| DCC3940 | Ova323-339 Peptide | Ovalbumin fragment peptide for study class II MHC-peptide binding and T-cell activation, binding to I-A(d) MHC class II protein, encompassing an allergenic and antigenic epitope of the ovalbumin protein |
|
| DCC3941 | Ovatodiolide | Narural broad anticancer agent, upregulating hsa-miR-155, suppressing the BCR-ABL fusion gene and dysregulating the PI3K/AKT/mTOR pathway |
|
| DCC3942 | Ov-potentiator-28 | First-in-class small molecule potentiator of cancer virotherapy, significantly enhancing virus replication-associated luciferase expression specifically in the tumor |
|
| DCC3943 | Ox02983 | Novel anthelmintic agent, immobilising whipworm and reducing the ability of embryonated T. muris eggs to establish infection in the mouse host in vivo |
|
| DCC3944 | Ox03699 | Novel anthelmintic agent |
|
| DCC3945 | Ox1r Antagonist 56 | Brain penetrant, selective and high affinity OX1R antagonist |
|
| DCC3946 | Ox2r-in-f7.3 | Novel selective Ligand for the Orexin 2 Receptor (OX2R) |
|
| DCC3947 | Oxa-06 Dihydrochloride | Potent inhibitor of PANC-1 cell migration and MYPT1 phosphorylation |
|
| DCC3948 | Oxaz-1 | Novel dual inhibitor of the p53 interaction with MDM2 and MDMX |
|
| DCC3949 | Oxeglitazar | PPARalpha/gamma agonist |
|
| DCC3950 | Oxendolone | Novel potent inhibitor of GVIA iPLA2 with little or no inhibition against GIVA cPLA2 (XI(50) = 0.0073 and >0.91, respectively) |
|
| DCC3951 | Oxfbd03 | Novel inhibitor of the bromodomain and extra terminal domain (BET) bromodomain family member BRD4(1) |
|
| DCC3952 | Oxiperomide Featured | Dual dopamine D2 and muscarinic M1 receptor ligand with putative antipsychotic and pro-cognitive potential |
|
| DCC3953 | Oxocarbazate | Novel inhibitor of human cathepsin L |
|
